Local identifiability for two and three-compartment pharmacokinetic models with time-lags.
暂无分享,去创建一个
Y Plusquellec | G Houin | G. Houin | J. A. Mérino | J. de Biasi | Y. Plusquellec | J A Merino | J De Biasi
[1] G. Houin,et al. Estimation of the effective amount entering the body for drugs subject to enterohepatic recirculations. , 1995, Medical engineering & physics.
[2] G. Houin,et al. Drug recirculation model with multiple cycles occurring at unequal time intervals. , 1992, Journal of biomedical engineering.
[3] Jacquez Ja. Identifiability: the first step in parameter estimation. , 1987 .
[4] Jacques Delforge,et al. On local identifiability of linear systems , 1984 .
[5] Eric Walter,et al. Identifiability of State Space Models: with applications to transformation systems , 1982 .
[6] G. Houin,et al. Mean residence time in multicompartmental models with time delays. , 1993, Journal of biomedical engineering.
[7] J. Delforge. New results on the problem of identifiability of a linear system , 1980 .
[8] Yves Lecourtier,et al. Unidentifiable compartmental models: what to do? , 1981 .
[9] Edward J. Davison. Connectability and structural controllability of composite systems , 1977, Autom..
[10] J. P. Norton,et al. Normal-mode identifiability analysis of linear compartmental systems in linear stages , 1980 .
[11] C. Cobelli,et al. Parameter and structural identifiability concepts and ambiguities: a critical review and analysis. , 1980, The American journal of physiology.
[12] R. Miller,et al. Pharmacokinetics and bioavailability of cimetidine in humans. , 1980, Journal of pharmaceutical sciences.
[13] W. Colburn. Pharmacokinetic analysis of concentration-time data obtained following administration of drugs that are recycled in the bile. , 1984, Journal of pharmaceutical sciences.
[14] J A Mérino,et al. Minimal experimental requirements for structural identifiability in linear compartmental models. The software 'IDEXMIN'. , 1996, Arzneimittel-Forschung.
[15] J. Boisvieux,et al. A time-lag model for pharmacokinetics of drugs subject to enterohepatic circulation. , 1982, Journal of pharmaceutical sciences.